Have a feature idea you'd love to see implemented?
Let us know!
EKSO Ekso Bionics Holdings Inc
Price (delayed)
$1.02
Market cap
$18.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.79
Enterprise value
$19.62M
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, Ekso
Highlights
EKSO's EPS is up by 35% year-on-year and by 19% since the previous quarter
The gross profit rose by 24% year-on-year and by 4.2% since the previous quarter
Ekso Bionics Holdings's equity has decreased by 32% YoY and by 14% QoQ
EKSO's quick ratio is down by 19% QoQ and by 11% YoY
Key stats
What are the main financial stats of EKSO
Market
Valuations
Earnings
Shares outstanding
18.44M
Market cap
$18.81M
Enterprise value
$19.62M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.54
Price to sales (P/S)
1.02
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.08
Revenue
$18.16M
EBIT
-$12.16M
EBITDA
-$10.34M
Free cash flow
-$11.14M
Per share
Balance sheet
Liquidity
EPS
-$0.79
Free cash flow per share
-$0.61
Book value per share
$0.66
Revenue per share
$1
TBVPS
$1.2
Total assets
$26.98M
Total liabilities
$14.93M
Debt
$6.69M
Equity
$12.06M
Working capital
$10.94M
Debt to equity
0.55
Current ratio
2.42
Quick ratio
1.61
Net debt/EBITDA
-0.08
Margins
Efficiency
Dividend
EBITDA margin
-57%
Gross margin
51.8%
Net margin
-68.4%
Operating margin
-65.9%
Return on assets
-42.8%
Return on equity
-92.1%
Return on invested capital
-82.7%
Return on capital employed
-63.1%
Return on sales
-67%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EKSO stock price
How has the Ekso Bionics Holdings stock price performed over time
Intraday
-0.97%
1 week
-0.97%
1 month
-17.07%
1 year
22.89%
YTD
-59.2%
QTD
-12.07%
Financial performance
How have Ekso Bionics Holdings's revenue and profit performed over time
Revenue
$18.16M
Gross profit
$9.41M
Operating income
-$11.97M
Net income
-$12.42M
Gross margin
51.8%
Net margin
-68.4%
EKSO's operating margin is up by 38% YoY and by 15% QoQ
The net margin is up by 33% YoY and by 14% QoQ
EKSO's operating income is up by 29% year-on-year and by 14% since the previous quarter
The gross profit rose by 24% year-on-year and by 4.2% since the previous quarter
Growth
What is Ekso Bionics Holdings's growth rate over time
Valuation
What is Ekso Bionics Holdings stock price valuation
P/E
N/A
P/B
1.54
P/S
1.02
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.08
EKSO's EPS is up by 35% year-on-year and by 19% since the previous quarter
EKSO's P/B is 33% below its 5-year quarterly average of 2.3 and 9% below its last 4 quarters average of 1.7
Ekso Bionics Holdings's equity has decreased by 32% YoY and by 14% QoQ
The stock's price to sales (P/S) is 65% less than its 5-year quarterly average of 2.9 and 15% less than its last 4 quarters average of 1.2
Ekso Bionics Holdings's revenue has increased by 16% YoY
Efficiency
How efficient is Ekso Bionics Holdings business performance
The ROIC has grown by 42% YoY and by 16% from the previous quarter
EKSO's return on sales is up by 34% year-on-year and by 14% since the previous quarter
The ROE has contracted by 33% YoY but it has grown by 3.5% from the previous quarter
The ROA has grown by 8% from the previous quarter
Dividends
What is EKSO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EKSO.
Financial health
How did Ekso Bionics Holdings financials performed over time
Ekso Bionics Holdings's total assets is 81% more than its total liabilities
Ekso Bionics Holdings's total assets has decreased by 21% YoY and by 7% from the previous quarter
EKSO's quick ratio is down by 19% QoQ and by 11% YoY
The debt is 45% lower than the equity
Ekso Bionics Holdings's equity has decreased by 32% YoY and by 14% QoQ
The debt to equity has grown by 31% year-on-year and by 12% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.